Lindsay LNN 深 滬
等待開盤 09-17 09:30:00 美东时间
118.23
-0.580
-0.49%
華盛通- 最 高119.90
- 今 開119.40
- 成交量 14.87万股
- 最 低 116.99
- 昨 收 118.81
- 總市值 12.02亿
- 52周最高 147.2526
- 市盈率 靜 17.43
- 換手率 1.46%
- 52周最低 96.52
- 委 比 0.00%
- 總股本 1016.89万
- 歷史最高 177.70
- 量 比 0.93
- 振 幅 2.45%
- 歷史最低 30.04
- 每 手 1
- 風險率 9.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Mayfield Director Increases Indirect Shareholding Through On‑Market Purchase
Mayfield Group Holdings Limited ( ($AU:MYG) ) has provided an update. Mayfield ...
09-15 15:52
Social Security Wage Cap Is the ‘Very First Thing’ Congress Should Remove, Democrat Says — Program Faces 2032 Funding Cliff
State Rep. Lindsay James (D-Iowa) said removing the wage cap on Social Security taxes and tying it to cost-of-living increases is one way Congress can shore up the program’s finances. James, the Democratic nominee for Iowa’s 2nd Congressional District, made the remarks on Wednesday during a Social S...
09-10 21:21
Ballard Mining Director Croser Receives Additional Long-Dated Options
Ballard Mining Limited ( ($AU:BM1) ) has shared an announcement. Ballard Mining...
09-07 14:54
Lindsay Appoints Interim Co-Chief Financial Officers
Lindsay ( ($LNN) ) has provided an announcement. On August 28, 2026, Lindsay Co...
08-29 04:53
Lindsay Australia Releases FY26 Full-Year Results Presentation
Lindsay Australia Limited ( ($AU:LAU) ) has provided an update. Lindsay Austral...
08-24 06:38
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
Arbutus Biopharma plans to launch a modified Dutch Auction tender offer to repurchase up to $230 million of its common shares at $5.00 to $5.75 per share, funded by cash on hand. The offer is expected to begin on August 24, 2026, and expire on September 29, 2026, subject to regulatory approvals. The company aims to return proceeds from its March 2026 settlement with Moderna to shareholders while continuing to enforce its intellectual property rig...
08-21 11:30
Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Arbutus Biopharma reported Q2 2026 financial results with $92.6M in cash, cash equivalents, and marketable securities. The company received $178M from Moderna's settlement and expects to return up to $230M to shareholders. Arbutus filed three international patent enforcement lawsuits against Pfizer and BioNTech over lipid nanoparticle (LNP) technology. The FDA granted Fast Track designation for imdusiran to treat chronic hepatitis B and aligned o...
08-12 11:30
华尔街锐评非农：这份报告“极其可怕”！
美国7月非农就业人数意外减少2.3万，远逊于市场预期。虽然季节性因素和世界杯红利消退扰乱了数据，但这仍显著削弱了美联储9月的加息动力，市场焦点转向下周CPI。
08-07 23:05
Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan
Applied Optoelectronics, Inc. granted 1,048 shares of common stock as inducement awards to 4 new employees under its 2023 Equity Inducement Plan. The restricted stock units vest over four years, contingent on continued employment. The company provides advanced optical and HFC networking products for AI datacenters and broadband networks, with facilities in the U.S., Taiwan, and China.
08-07 12:15
Ethan Allen holder takes stake, pushes for new board
Ethan Allen Interiors (ETD) holder Doug Bergeron has built a stake in the furniture company and wants to replace the entire board of directors. Shares of Ethan Allen rose 1.8%. Bergeron's DGB Investme...
08-05 22:15
